MSP for Strathkelvin and Bearsden (Constituency)
The Scottish Parliament
Edinburgh
EH99 1SP
Scottish Liberal Democrats
MSP for Strathkelvin and Bearsden (Constituency)
07 May 2026 to present
Substitute Member
Member
Scottish Liberal Democrats
Previous roles in cross-party groups are not included in this list.
MSPs must provide details of their financial interests in the Register of Interests. They make an initial statement on becoming or being returned as an MSP. This is then updated with any changes they provide.
These are the official transcripts of what was said by this MSP in the chamber and at committee meetings. You'll find the topic discussed and how many times this MSP has contributed to the discussion.
Chamber meeting date: 9 June 2026
Adam Harley (Strathkelvin and Bearsden) (LD): "I thank Patricia Gibson for bringing this important debate to the chamber and for raising awareness of pre-eclampsia. I also thank her for her powerful testimony, and I thank members across the chamber for their testimony…
Chamber meeting date: 2 June 2026
Adam Harley (Strathkelvin and Bearsden) (LD): "As this is my first speech, I pay tribute to my predecessor, Rona Mackay, who served the people of Strathkelvin and Bearsden for a decade. I thank her for her efforts in the community over that time…
Chamber meeting date: 19 May 2026
Adam Harley (Strathkelvin and Bearsden) (LD): "To ask the Scottish Government what discussions it has had with Police Scotland, local authorities and football stakeholders following the disorder seen in Glasgow city centre last weekend."
Chamber meeting date: 14 May 2026
Adam Harley (Strathkelvin and Bearsden) (LD): "I, Adam Harley, do swear that I will be faithful and bear true allegiance to His Majesty King Charles, his heirs and successors, according to law. So help me God."
Read all of Adam Harley's contributions in the Debating Chamber
This MSP has not made any contributions yet. Information will be added here when available.
Find out what motions Adam Harley has submitted recently.
These are the questions that this MSP has asked in Parliament. It also includes any answer to those questions.
Asked by: Adam Harley, Strathkelvin and Bearsden, Scottish Liberal Democrats
Date lodged: 7 October 2026
Current Status: Answer expected on 4 November 2026
"To ask the Scottish Government what discussions it has had with Biogen to facilitate the resubmission of Skyclarys (omaveloxolone) to the Scottish Medicines Consortium for consideration for use within NHS Scotland, and what specific action it has taken as a result."
Asked by: Adam Harley, Strathkelvin and Bearsden, Scottish Liberal Democrats
Date lodged: 7 October 2026
Current Status: Answer expected on 4 November 2026
"To ask the Scottish Government what steps it is taking to ensure that NHS Scotland is prepared for future treatments for Friedreich’s ataxia, including those that might become available for children and young people."
Asked by: Adam Harley, Strathkelvin and Bearsden, Scottish Liberal Democrats
Date lodged: 7 October 2026
Current Status: Answer expected on 4 November 2026
"To ask the Scottish Government what assessment it has made of any barriers that would need to be addressed by Biogen before Skyclarys (omaveloxolone) could be resubmitted to the Scottish Medicines Consortium for consideration for use within NHS Scotland."
Asked by: Adam Harley, Strathkelvin and Bearsden, Scottish Liberal Democrats
Date lodged: 7 October 2026
Current Status: Answer expected on 4 November 2026
"To ask the Scottish Government how many applications for access to Skyclarys (omaveloxolone) have been made through the Patient Access to Care Services (PACS) Tier 2 process in each NHS board area since the medicine became available in the UK and, for each NHS board area, how many applications have been approved."
Asked by: Adam Harley, Strathkelvin and Bearsden, Scottish Liberal Democrats
Date lodged: 7 October 2026
Current Status: Answer expected on 4 November 2026
"To ask the Scottish Government whether its Access to New Medicines Horizon Scanning Advisory Board is currently considering Friedreich’s ataxia and emerging treatments for the condition, and, if so, which treatments are being monitored."
Asked by: Adam Harley, Strathkelvin and Bearsden, Scottish Liberal Democrats
Date lodged: 24 September 2026
Current Status: Answered by Kirsten Oswald on 6 October 2026
"To ask the Scottish Government whether it plans to introduce further regulation on the sale of fireworks to prevent antisocial behaviour and negative impacts on local residents."
Asked by: Adam Harley, Strathkelvin and Bearsden, Scottish Liberal Democrats
Date lodged: 1 October 2026
Current Status: Answer expected on 29 October 2026
"To ask the Scottish Government what assessment it has made of Recommendation 16 of the Thirlwall Inquiry, and whether it considers that existing arrangements in Scotland provide healthcare whistle-blowers with sufficiently independent support and oversight where concerns have not been adequately addressed by an NHS board."
Asked by: Adam Harley, Strathkelvin and Bearsden, Scottish Liberal Democrats
Date lodged: 1 October 2026
Current Status: Answer expected on 29 October 2026
"To ask the Scottish Government what mechanisms exist to prevent an NHS manager who has been found responsible for serious misconduct or patient safety failings from moving into a management role in another NHS board, and whether it will review these arrangements in light of Recommendation 13 of the Thirlwall Inquiry."
Asked by: Adam Harley, Strathkelvin and Bearsden, Scottish Liberal Democrats
Date lodged: 1 October 2026
Current Status: Answer expected on 29 October 2026
"To ask the Scottish Government what safeguards are currently in place in neonatal units to control and record access to insulin, and whether, in response to Recommendation 2 of the Thirlwall Inquiry, it will introduce digital access controls and monitoring of insulin storage."
Asked by: Adam Harley, Strathkelvin and Bearsden, Scottish Liberal Democrats
Date lodged: 1 October 2026
Current Status: Answer expected on 29 October 2026
"To ask the Scottish Government whether, in light of Recommendation 10 of the Thirlwall Inquiry, it will consider establishing a national panel of independent clinical and other experts that NHS boards could call upon to conduct rapid, independent investigations where concerns emerge about possible harm being caused to patients."